KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Cash & Equivalents (2017 - 2026)

Arcosa's Cash & Equivalents history spans 10 years, with the latest figure at $153.2 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 8.76% to $153.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $153.2 million, a 8.76% decrease, with the full-year FY2025 number at $214.6 million, up 14.58% from a year prior.
  • Cash & Equivalents hit $153.2 million in Q1 2026 for Arcosa, down from $214.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ACA hit a ceiling of $756.8 million in Q3 2024 and a floor of $77.0 million in Q2 2022.
  • Historically, Cash & Equivalents has averaged $189.1 million across 5 years, with a median of $160.4 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: soared 387.31% in 2024 and later plummeted 70.93% in 2025.
  • Tracing ACA's Cash & Equivalents over 5 years: stood at $160.4 million in 2022, then plummeted by 34.66% to $104.8 million in 2023, then surged by 78.72% to $187.3 million in 2024, then rose by 14.58% to $214.6 million in 2025, then dropped by 28.61% to $153.2 million in 2026.
  • Business Quant data shows Cash & Equivalents for ACA at $153.2 million in Q1 2026, $214.6 million in Q4 2025, and $220.0 million in Q3 2025.